Level Four Advisory Services, LLC Immunic, Inc. Transaction History
Level Four Advisory Services, LLC
- $2.27 Billion
- Q1 2025
A detailed history of Level Four Advisory Services, LLC transactions in Immunic, Inc. stock. As of the latest transaction made, Level Four Advisory Services, LLC holds 11,167 shares of IMUX stock, worth $9,715. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,167
Previous 11,167
-0.0%
Holding current value
$9,715
Previous $11,000
9.09%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding IMUX
# of Institutions
71Shares Held
47.2MCall Options Held
1.14MPut Options Held
130K-
Bvf Inc San Francisco, CA8.9MShares$7.75 Million0.43% of portfolio
-
Abrdn PLC8.24MShares$7.17 Million0.01% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT7.29MShares$6.34 Million0.66% of portfolio
-
Avidity Partners Management LP Dallas, TX4.45MShares$3.88 Million1.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.13MShares$3.59 Million0.0% of portfolio
About IMMUNIC, INC.
- Ticker IMUX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,565,000
- Market Cap $26.6M
- Description
- Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and oth...